Document is current

Article History

Accepted: 6 June 2024

First Online: 1 July 2024

Declarations

:

: No funding was provided for this article.

: Dr. Ortega-Loayza is President-elect of the Pacific Dermatology Association and serves as an associate editor for <i>Dermatology</i>. Dr. Ortega-Loayza is an Editorial Board member of the <i>American Journal of Clinical Dermatology</i>. Dr. Ortega-Loayza was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Additionally, he is a consultant for Genentech, Guidepoint, Corvus Pharmaceuticals, Castle Biosciences, Clarivate, InflaRx GmbH, TFS Health Science, Otsuka, and Sitala Bio Ltd, and an advisor to Bristol Myers Squibb, Boehringer Ingelheim, Janssen, Biotech, and Sanofi. Dr. Ortega-Loayza has received research grants from Lilly, Janssen, Pfizer, AbbVie, Incyte, Boehringer Ingelheim, and InflaRx GmbH. He is supported by NIH NIAMS R01 AR083110. The other authors have no conflicts of interest to disclose.

: Not applicable.

: Data available within the article or its supplementary materials.

: Not applicable.

: Not applicable.

: AGOL was responsible for conceptualization of the study, and supervision was provided by AGOL and BW. CDP performed the search strategy development and literature search. YO and DRA were responsible for data collection and writing of the initial draft. All authors contributed to data interpretation and critical revision of the manuscript. All authors read and approved the final manuscript.